Delivery Order HHSN261201200018I-HHSN26100006

This is a task order award under Contract 75N91019D00025 with the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The task order is for the manufacture of a vaccine targeting frame-shift mutations characteristic of tumors with microsatellite instability. The prime contractor is Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization specializing in gene therapies, vaccines, oncolytics, and...

This is a modification to an existing delivery order contract (#HHSO10020160004I, Task Order 75A50119F33009) awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to GlaxoSmithKline, LLC. The purpose of the modification is to extend the period of performance from August 28, 2019 to February 28, 2024, to a new end date of April 30, 2024. The contract is for an AS03B-H7N9 vaccine clinical study, with a total ceiling value of $18,161,554.28. The contract is a firm...

This is a task order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases to Battelle Memorial Institute, doing business as Battelle, a nonprofit research and development organization, to design, conduct, and assess the immunogenicity and efficacy of a plague vaccine candidate formulated with IL-2 alum-cytuvax or other novel adjuvant in mice. The task order is part of the Evaluation and Testing...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 1, 2015, under the Simian Vaccine Evaluation Units 2013–2020 IDIQ, with a ceiling value of $317,935.03.</p> <p>Work is performed in Rockville, MD. The order covers evaluation and development activities for simian vaccine units under a cost-plus-fixed-fee pricing structure. Ultimate completion is scheduled for April 30, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 16, 2014, with a ceiling value of $240,661.57 under the Simian Vaccine Evaluation Units 2013-2020 parent IDIQ for evaluation of simian vaccines.</p> <p>Place of performance is Rockville, MD. The order has a Cost Plus Fixed Fee pricing structure and is scheduled for ultimate completion by July 31, 2018.</p>

This task order funds the guaranteed minimum amount under a preexisting master indefinite-delivery/indefinite-quantity contract between the National Institutes of Health's National Institute of Allergy and Infectious Diseases and Advanced Bioscience Laboratories, Inc. The purpose is to support preclinical and translational vaccine development for HIV and other candidate agents. The $2,500 delivery order was awarded on December 1, 2021 with a one-year period of performance ending November 30,...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 24, 2012, with a ceiling value of $3,015,314.33 for manufacture and characterization services for vaccines and other biologics for infectious diseases, including cholera Inaba OSP-core tetanus toxin heavy chain vaccine. Place of performance is Rockville, MD 20850. The order was priced as cost plus fixed fee with no set-aside designation. The ultimate completion...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 2, 2016, under the Preclinical Services for Biopharmaceutical Product Development IDIQ for preclinical services and management functions in support of biopharmaceutical product development (Task Order Area F). The order ceiling is $8,185.43, issued on firm fixed price terms with no set-aside. Place of performance is Rockville, MD 20850. Work is scheduled for...

This is a delivery order (contract type: cost plus fixed fee) awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Battelle Memorial Institute, doing business as Battelle, for $2,026,616.68. The contract is for preparedness and testing services for NIAID priority vaccines, including neurovirulence and reproductive toxicology studies. This work supports the EVALUATION AND TESTING SERVICES (ETS) FOR...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 26, 2014, with a ceiling value of $1,260,134.13 for preclinical development support and toxicity testing for the CH505 T/F GP120 protein. The order is a cost-plus-fixed-fee engagement with place of performance in Rockville, MD. Performance extends through August 31, 2017. The work encompasses toxicity testing and preclinical development services in support of...